TRV GP VI, LLC
An institutional investment manager in Boston, MA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 10, 2026. SEC CIK 1990716.
- Reported value$232.3m
- Positions4
Holdings: 4 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Septerna, Inc.SEPN | COM | 81734D104 | 141 | 60.7% | 4,211,659 | Unchanged | |
| Seaport Thereapeutics, Inc.SPTX | COM | 81221K108 | 44.8 | 19.3% | 2,061,222 | New+2,061,222 | |
| Rapport Therapeutics, Inc.RAPP | COM | 75383L102 | 40.4 | 17.4% | 969,218 | Unchanged | |
| Tango Therapeutics, Inc.TNGX | COM | 87583X109 | 6.1 | 2.6% | 194,174 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-340715 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.